Assembly Biosciences, Inc. (ASMB) NASDAQ

14.18

+2.74(+23.95%)

Updated at May 02 04:00PM

Currency In USD

Valuation

Market Cap94.75M
Enterprise Value59.5M
P/E Ratio-2.32
PEG Ratio-0.59
Price/Sales Ratio3.73
Price/Book Ratio2.8
Enterprise/Revenue2.49
Enterprise/EBITDA-1.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-1.41
Operating Margin-1.59

Management Effectiveness

Return On Assets-0.34
Return On Equity-1.27

Income Statement

Revenue28.52M
Revenue/Share4.33
Gross Profit28.39M
EBITDA-45.42M
Net Income-40.18M
Diluted EPS-6.69

Balance Sheet

Total Cash112.08M
Total Cash/Share17.03
Total Debt3.09M
Total Debt/Equity0.09
Current Ratio2.42
Book Value Per Share5.07

Price History

52-Week Change7.83
52-Week High19.93
52-Week Low7.75
Moving Average 50 Days10.79
Moving Average 200 Days14.33

Statistics

Average Volume28,288
Shares Outstanding7.5M
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateFebruary 12, 2024